An in line trading update should reassure that Quantum’s new management team is delivering on its promises. EBITDA is expected to be in line with expectations and, pleasingly, Net Debt is expected to be ~£1m lower, reflecting the focus on cash management. All the UL2L products in the pipeline are now in active development and work has begun on broadening the group’s commercial network to help monetise the generic products already developed. We make no change to our forecasts and look forward to ....
